The FY26 Lung Cancer Research Program Translational Research Award supports advanced translational studies aimed at transforming promising lung cancer research into clinical applications. Funding is available for advanced preclinical work, correlative studies, and pilot clinical trials of novel interventions addressing specified research priorities.
Open to any type of entity, with no explicit restrictions stated. Applicants must address specified lung cancer research areas.
